US Stock MarketDetailed Quotes

TCRX TScan Therapeutics

Watchlist
  • 5.370
  • +0.110+2.09%
Close Oct 18 16:00 ET
  • 5.260
  • -0.110-2.05%
Post 16:37 ET
284.47MMarket Cap-8261P/E (TTM)

TScan Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
-82.97%536K
-91.68%566K
55.52%21.05M
132.99%7.21M
15.58%3.89M
-22.39%3.15M
125.19%6.8M
33.47%13.54M
8.44%3.1M
39.43%3.36M
Operating revenue
-82.97%536K
-91.68%566K
55.52%21.05M
132.99%7.21M
15.58%3.89M
-22.39%3.15M
125.19%6.8M
33.47%13.54M
8.44%3.1M
39.43%3.36M
Cost of revenue
Gross profit
Operating expense
24.83%34.65M
8.10%31.94M
42.83%114.51M
31.38%28.57M
43.60%28.64M
43.81%27.76M
54.01%29.55M
36.39%80.17M
27.49%21.74M
9.24%19.94M
Selling and administrative expenses
19.02%7.77M
-8.82%7.08M
29.49%26.35M
0.36%6.16M
20.04%5.89M
35.84%6.53M
72.83%7.77M
47.18%20.35M
38.04%6.14M
21.29%4.91M
-General and administrative expense
19.02%7.77M
-8.82%7.08M
29.49%26.35M
0.36%6.16M
20.04%5.89M
35.84%6.53M
72.83%7.77M
47.18%20.35M
38.04%6.14M
21.29%4.91M
Research and development costs
26.62%26.88M
14.13%24.86M
47.37%88.15M
43.59%22.41M
51.29%22.74M
46.45%21.23M
48.26%21.78M
33.07%59.82M
23.76%15.6M
5.81%15.03M
Operating profit
-38.62%-34.11M
-37.95%-31.37M
-40.25%-93.46M
-14.52%-21.36M
-49.28%-24.75M
-61.42%-24.61M
-40.71%-22.74M
-37.00%-66.64M
-31.31%-18.65M
-4.65%-16.58M
Net non-operating interest income expense
334.16%2.45M
583.89%1.23M
921.69%4.24M
2,456.76%1.74M
425.83%1.75M
279.19%565K
2,471.43%180K
2,493.75%415K
-3,800.00%-74K
11,000.00%333K
Non-operating interest income
121.97%3.41M
92.78%2.19M
402.77%8M
188.12%2.6M
411.80%2.73M
929.53%1.53M
16,128.57%1.14M
9,843.75%1.59M
44,950.00%901K
17,700.00%534K
Non-operating interest expense
-1.75%952K
0.31%959K
219.64%3.76M
-12.62%852K
388.56%982K
--969K
--956K
--1.18M
--975K
--201K
Other net income (expense)
Income before tax
-31.67%-31.66M
-33.59%-30.14M
-34.73%-89.22M
-4.75%-19.61M
-41.56%-23M
-59.27%-24.05M
-39.66%-22.56M
-36.19%-66.22M
-31.85%-18.72M
-2.56%-16.25M
Income tax
Net income
-31.67%-31.66M
-33.59%-30.14M
-34.73%-89.22M
-4.75%-19.61M
-41.56%-23M
-59.27%-24.05M
-39.66%-22.56M
-36.19%-66.22M
-31.85%-18.72M
-2.56%-16.25M
Net income continuous Operations
-31.67%-31.66M
-33.59%-30.14M
-34.73%-89.22M
-4.75%-19.61M
-41.56%-23M
-59.27%-24.05M
-39.66%-22.56M
-36.19%-66.22M
-31.85%-18.72M
-2.56%-16.25M
Minority interest income
Net income attributable to the parent company
-31.67%-31.66M
-33.59%-30.14M
-34.73%-89.22M
-4.75%-19.61M
-41.56%-23M
-59.27%-24.05M
-39.66%-22.56M
-36.19%-66.22M
-31.85%-18.72M
-2.56%-16.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-31.67%-31.66M
-33.59%-30.14M
-34.73%-89.22M
-4.75%-19.61M
-41.56%-23M
-59.27%-24.05M
-39.66%-22.56M
-36.19%-66.22M
-31.85%-18.72M
-2.56%-16.25M
Basic earnings per share
45.10%-0.28
65.59%-0.32
50.55%-1.36
85.90%-0.11
64.18%-0.24
19.05%-0.51
-38.81%-0.93
34.05%-2.75
-31.32%-0.78
16.25%-0.67
Diluted earnings per share
45.10%-0.28
65.59%-0.32
50.55%-1.36
85.90%-0.11
64.18%-0.24
19.05%-0.51
-38.81%-0.93
34.05%-2.75
-31.32%-0.78
16.25%-0.67
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue -82.97%536K-91.68%566K55.52%21.05M132.99%7.21M15.58%3.89M-22.39%3.15M125.19%6.8M33.47%13.54M8.44%3.1M39.43%3.36M
Operating revenue -82.97%536K-91.68%566K55.52%21.05M132.99%7.21M15.58%3.89M-22.39%3.15M125.19%6.8M33.47%13.54M8.44%3.1M39.43%3.36M
Cost of revenue
Gross profit
Operating expense 24.83%34.65M8.10%31.94M42.83%114.51M31.38%28.57M43.60%28.64M43.81%27.76M54.01%29.55M36.39%80.17M27.49%21.74M9.24%19.94M
Selling and administrative expenses 19.02%7.77M-8.82%7.08M29.49%26.35M0.36%6.16M20.04%5.89M35.84%6.53M72.83%7.77M47.18%20.35M38.04%6.14M21.29%4.91M
-General and administrative expense 19.02%7.77M-8.82%7.08M29.49%26.35M0.36%6.16M20.04%5.89M35.84%6.53M72.83%7.77M47.18%20.35M38.04%6.14M21.29%4.91M
Research and development costs 26.62%26.88M14.13%24.86M47.37%88.15M43.59%22.41M51.29%22.74M46.45%21.23M48.26%21.78M33.07%59.82M23.76%15.6M5.81%15.03M
Operating profit -38.62%-34.11M-37.95%-31.37M-40.25%-93.46M-14.52%-21.36M-49.28%-24.75M-61.42%-24.61M-40.71%-22.74M-37.00%-66.64M-31.31%-18.65M-4.65%-16.58M
Net non-operating interest income expense 334.16%2.45M583.89%1.23M921.69%4.24M2,456.76%1.74M425.83%1.75M279.19%565K2,471.43%180K2,493.75%415K-3,800.00%-74K11,000.00%333K
Non-operating interest income 121.97%3.41M92.78%2.19M402.77%8M188.12%2.6M411.80%2.73M929.53%1.53M16,128.57%1.14M9,843.75%1.59M44,950.00%901K17,700.00%534K
Non-operating interest expense -1.75%952K0.31%959K219.64%3.76M-12.62%852K388.56%982K--969K--956K--1.18M--975K--201K
Other net income (expense)
Income before tax -31.67%-31.66M-33.59%-30.14M-34.73%-89.22M-4.75%-19.61M-41.56%-23M-59.27%-24.05M-39.66%-22.56M-36.19%-66.22M-31.85%-18.72M-2.56%-16.25M
Income tax
Net income -31.67%-31.66M-33.59%-30.14M-34.73%-89.22M-4.75%-19.61M-41.56%-23M-59.27%-24.05M-39.66%-22.56M-36.19%-66.22M-31.85%-18.72M-2.56%-16.25M
Net income continuous Operations -31.67%-31.66M-33.59%-30.14M-34.73%-89.22M-4.75%-19.61M-41.56%-23M-59.27%-24.05M-39.66%-22.56M-36.19%-66.22M-31.85%-18.72M-2.56%-16.25M
Minority interest income
Net income attributable to the parent company -31.67%-31.66M-33.59%-30.14M-34.73%-89.22M-4.75%-19.61M-41.56%-23M-59.27%-24.05M-39.66%-22.56M-36.19%-66.22M-31.85%-18.72M-2.56%-16.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -31.67%-31.66M-33.59%-30.14M-34.73%-89.22M-4.75%-19.61M-41.56%-23M-59.27%-24.05M-39.66%-22.56M-36.19%-66.22M-31.85%-18.72M-2.56%-16.25M
Basic earnings per share 45.10%-0.2865.59%-0.3250.55%-1.3685.90%-0.1164.18%-0.2419.05%-0.51-38.81%-0.9334.05%-2.75-31.32%-0.7816.25%-0.67
Diluted earnings per share 45.10%-0.2865.59%-0.3250.55%-1.3685.90%-0.1164.18%-0.2419.05%-0.51-38.81%-0.9334.05%-2.75-31.32%-0.7816.25%-0.67
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data